AbbVie Inc. stock gains on Apogee deal and blood cancer trial progress
AbbVie Inc. stock gains on Apogee deal and blood cancer trial progress AD HOC NEWS
Covered in this story
Summary aggregated from AD HOC NEWS's public RSS feed. The full reporting belongs to AD HOC NEWS — please read it on their site.